Meani E, Romanõ C
Istituto Ortopedico Gaetano Pini, Sezione Settici Clinica Ortopedica Dell'Università, Milan, Italie.
Rev Chir Orthop Reparatrice Appar Mot. 1994;80(4):285-90.
Systemic administration of antibiotics in osteoarticular infections is characterized by: 1) systemic side effects: 2) questionable penetration of the antibiotic into the infected and ischaemic areas: 3) mandatory hospitalization for prolonged administration of antibiotics. Aware of these difficulties, orthopedic surgeons have long been seeking an effective method of local antibiotic administration. The authors report their original experience with the use of an external, portable electronic micro pump for continuous local delivery of antibiotics in conjunction with surgical debridement, in the treatment of osteomyelitis.
Ten patients with active chronic osteomyelitis, were treated with surgical debridement and local antibiotic therapy. On the basis of the sensitivity disk findings, vancomycin or amikacin was delivered locally through an external portable, electronically programmable micro pump. To connect the pump with the infected site Groshong or Buchwald catheters were employed. The reservoir of the pump was refilled every 10-15 days.
The duration of symptoms ranged from six months to fifteen years. All patients had undergone at least one previous unsuccessful treatment consisting of surgical debridement and/or prolonged intravenous antibiotic therapy. The duration of the infusion therapy ranged from 80 to 207 days (mean 109 +/- 37.7). At 33.7 +/- 5.6 months follow-up (range twenty-one to thirty-nine months) eight patients out of nine (one patient was lost to follow-up), showed no recurrence of the infection as manifested by clinical, laboratory and imaging data. Serum vancomycin and amikacin levels, measured at different intervals from the beginning of therapy, were always well below the recommended through levels for systemic infusion. There were no side effects linked to the prolonged administration of antibiotics, no technical complications connected with the implantation and removal of the catheter and no infections of inflammation of subcutaneous tissue where the catheter had been placed or of the skin around the catheter.
The use of subcutaneous, totally implantable infusion drugs pumps, as proposed by Clayton, Perry and co-workers (1986) allows: 1) to maintain adequate local levels of a wide variety of antibiotics for a long period of time, avoiding systemic toxicity; 2) to stop the infusion in case of adverse reactions (allergic response): 3) to administer the treatment on an outpatient basis. Our original proposal of an externally portable micro pump adds the following advantages: 1) it is less invasive: 2) no risk of infection of the subcutaneous pocket where the pump is lodged: 3) better stability of the antibiotic, being at ambient temperature instead of at nearly 30 degrees C: 4) much lower cost, the external pump being less expensive than an implantable one and is reusable.
Our experience shows: 1) the simplicity and limited invasiveness of this technique, which, without excluding other forms of therapy, allows to deliver antibiotics in the infected focus for months; 2) the absence of side effects and technical complications; 3) the good quality of life of the patients during the treatment; 4) the low cost for the health care system, since the patients are followed-up and the reservoirs refilled on an out-patient basis.
骨关节炎感染全身性使用抗生素具有以下特点:1)全身性副作用;2)抗生素进入感染及缺血区域的渗透情况存疑;3)因需长期使用抗生素而必须住院。鉴于这些困难,骨科医生长期以来一直在寻找有效的局部抗生素给药方法。作者报告了他们使用外部便携式电子微型泵连续局部输送抗生素并结合手术清创治疗骨髓炎的原始经验。
10例活动性慢性骨髓炎患者接受了手术清创和局部抗生素治疗。根据药敏试验结果,通过外部便携式电子可编程微型泵局部输送万古霉素或阿米卡星。使用格罗雄(Groshong)导管或布赫瓦尔德(Buchwald)导管将泵与感染部位相连。泵的储液器每10 - 15天补充一次。
症状持续时间为6个月至15年。所有患者此前至少接受过一次包括手术清创和/或长期静脉抗生素治疗但未成功的治疗。输注治疗持续时间为80至207天(平均109±37.7天)。在33.7±5.6个月的随访期(范围为21至39个月)内,9例患者中有8例(1例失访)经临床、实验室和影像学检查未显示感染复发。从治疗开始不同时间点测量的血清万古霉素和阿米卡星水平始终远低于全身输注的推荐阈值。未出现与长期使用抗生素相关的副作用,未出现与导管植入和拔除相关的技术并发症,且在放置导管的皮下组织或导管周围皮肤未发生感染或炎症。
克莱顿(Clayton)、佩里(Perry)及其同事(1986年)提出的皮下完全植入式输液泵的使用具有以下优点:1)能够长时间维持多种抗生素的足够局部水平,避免全身毒性;2)在出现不良反应(过敏反应)时可停止输注;3)可在门诊进行治疗。我们提出的外部便携式微型泵还有以下优点:1)侵入性较小;2)泵所在的皮下囊袋无感染风险;3)抗生素稳定性更好,因为处于环境温度而非近30摄氏度;4)成本低得多,外部泵比植入式泵便宜且可重复使用。
我们的经验表明:1)该技术简单且侵入性有限,在不排除其他治疗形式的情况下,可在感染灶持续输送抗生素数月;2)无副作用和技术并发症;3)患者在治疗期间生活质量良好;4)对医疗保健系统成本低,因为患者可门诊随访且储液器可门诊补充。